ACME Laboratories Ltd. With a robust portfolio of over 800 products across various dosage forms, ACME addresses a broad range of therapeutic areas, including pharmaceuticals, herbal and nutraceuticals, ayurvedic, and veterinary medicines. The company emphasizes innovation and quality, producing specialized products such as metered dose inhalers, dry powder inhalers, lyophilized injectables, and various nasal sprays, all crafted with state-of-the-art technology compliant with international standards.

ACME's manufacturing facilities span 35 acres and are accredited by regulatory bodies including the US FDA and UK MHRA, ensuring top-tier quality and safety. The company's commitment to continuous improvement and global expansion reflects its vision for high-quality healthcare solutions. Alongside its dedication to health, ACME champions corporate social responsibility, focusing on employee welfare, environmental sustainability, and social contributions. ACME Laboratories embodies the promise of care in health, continuously striving for excellence and innovation.